A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
Nuvation Bio Inc.
Nuvation Bio Inc.
Hoffmann-La Roche
EpicentRx, Inc.
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Stanford University
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Novartis
Rutgers, The State University of New Jersey